154 related articles for article (PubMed ID: 26596782)
1. The Bromodomain: A New Target in Emerging Epigenetic Medicine.
Smith SG; Zhou MM
ACS Chem Biol; 2016 Mar; 11(3):598-608. PubMed ID: 26596782
[TBL] [Abstract][Full Text] [Related]
2. An Activity-Based Probe Targeting Non-Catalytic, Highly Conserved Amino Acid Residues within Bromodomains.
D'Ascenzio M; Pugh KM; Konietzny R; Berridge G; Tallant C; Hashem S; Monteiro O; Thomas JR; Schirle M; Knapp S; Marsden B; Fedorov O; Bountra C; Kessler BM; Brennan PE
Angew Chem Int Ed Engl; 2019 Jan; 58(4):1007-1012. PubMed ID: 30589164
[TBL] [Abstract][Full Text] [Related]
3. Functional Roles of Bromodomain Proteins in Cancer.
Boyson SP; Gao C; Quinn K; Boyd J; Paculova H; Frietze S; Glass KC
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298819
[TBL] [Abstract][Full Text] [Related]
4. A Novel Epi-drug Therapy Based on the Suppression of BET Family Epigenetic Readers.
Shin DG; Bayarsaihan D
Yale J Biol Med; 2017 Mar; 90(1):63-71. PubMed ID: 28356894
[TBL] [Abstract][Full Text] [Related]
5. Targeting bromodomian-containing protein 8 (BRD8): An advanced tool to interrogate BRD8.
Wu T; Chen Y; You Q; Jiang Z; Chen X
Eur J Med Chem; 2024 Mar; 268():116271. PubMed ID: 38401187
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic targeting of BET bromodomain and other epigenetic acetylrecognition domain-containing factors.
Gold S; Shilatifard A
Curr Opin Genet Dev; 2024 Apr; 86():102181. PubMed ID: 38564841
[TBL] [Abstract][Full Text] [Related]
7. Identifying Small-Molecule Binding Sites for Epigenetic Proteins at Domain-Domain Interfaces.
Bowkett D; Talon R; Tallant C; Schofield C; von Delft F; Knapp S; Bruton G; Brennan PE
ChemMedChem; 2018 May; 13(10):1051-1057. PubMed ID: 29578648
[TBL] [Abstract][Full Text] [Related]
8. Design of Class I/IV Bromodomain-Targeting Degraders for Chromatin Remodeling Complexes.
Zahid H; Costello JP; Li Y; Kimbrough JR; Actis M; Rankovic Z; Yan Q; Pomerantz WCK
ACS Chem Biol; 2023 Jun; 18(6):1278-1293. PubMed ID: 37260298
[TBL] [Abstract][Full Text] [Related]
9. Photoaffinity labelling displacement assay using multiple recombinant protein domains.
Fallon DJ; Phillipou A; Schofield CJ; House D; Tomkinson NCO; Bush JT
Biochem J; 2023 Aug; 480(15):1183-1197. PubMed ID: 37401534
[TBL] [Abstract][Full Text] [Related]
10. Bromodomains: Structure, function and pharmacology of inhibition.
Ferri E; Petosa C; McKenna CE
Biochem Pharmacol; 2016 Apr; 106():1-18. PubMed ID: 26707800
[TBL] [Abstract][Full Text] [Related]
11. Large-Scale Computational Screening Identifies First in Class Multitarget Inhibitor of EGFR Kinase and BRD4.
Allen BK; Mehta S; Ember SW; Schonbrunn E; Ayad N; Schürer SC
Sci Rep; 2015 Nov; 5():16924. PubMed ID: 26596901
[TBL] [Abstract][Full Text] [Related]
12. Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition.
Henssen A; Althoff K; Odersky A; Beckers A; Koche R; Speleman F; Schäfers S; Bell E; Nortmeyer M; Westermann F; De Preter K; Florin A; Heukamp L; Spruessel A; Astrahanseff K; Lindner S; Sadowski N; Schramm A; Astorgues-Xerri L; Riveiro ME; Eggert A; Cvitkovic E; Schulte JH
Clin Cancer Res; 2016 May; 22(10):2470-81. PubMed ID: 26631615
[TBL] [Abstract][Full Text] [Related]
13. A Bead-Based Proximity Assay for BRD4 Ligand Discovery.
Roberts JM; Bradner JE
Curr Protoc Chem Biol; 2015 Dec; 7(4):263-278. PubMed ID: 26629616
[TBL] [Abstract][Full Text] [Related]
14. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins.
Taniguchi Y
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827996
[TBL] [Abstract][Full Text] [Related]
15. Targeting BET bromodomain proteins in solid tumors.
Sahai V; Redig AJ; Collier KA; Eckerdt FD; Munshi HG
Oncotarget; 2016 Aug; 7(33):53997-54009. PubMed ID: 27283767
[TBL] [Abstract][Full Text] [Related]
16. BET Bromodomain as a Target of Epigenetic Therapy.
Noguchi-Yachide T
Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788
[TBL] [Abstract][Full Text] [Related]
17. BRD4 is a novel therapeutic target for liver fibrosis.
Ding N; Hah N; Yu RT; Sherman MH; Benner C; Leblanc M; He M; Liddle C; Downes M; Evans RM
Proc Natl Acad Sci U S A; 2015 Dec; 112(51):15713-8. PubMed ID: 26644586
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional Profiling of a Selective CREB Binding Protein Bromodomain Inhibitor Highlights Therapeutic Opportunities.
Chekler EL; Pellegrino JA; Lanz TA; Denny RA; Flick AC; Coe J; Langille J; Basak A; Liu S; Stock IA; Sahasrabudhe P; Bonin PD; Lee K; Pletcher MT; Jones LH
Chem Biol; 2015 Dec; 22(12):1588-96. PubMed ID: 26670081
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial protection impairs BET bromodomain inhibitor-mediated cell death and provides rationale for combination therapeutic strategies.
Lasorsa E; Smonksey M; Kirk JS; Rosario S; Hernandez-Ilizaliturri FJ; Ellis L
Cell Death Dis; 2015 Dec; 6(12):e2014. PubMed ID: 26658189
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic mechanisms and drug discovery in rheumatology.
Tough DF; Prinjha RK; Tak PP
Clin Med (Lond); 2015 Dec; 15 Suppl 6():s64-71. PubMed ID: 26634685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
